This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Washington. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Stephanie Ann Berger: Innovator in Cancer Research
Introduction
Stephanie Ann Berger is a prominent inventor based in Seattle, WA. She has made significant contributions to the field of cancer research, particularly in the development of therapeutic solutions targeting Epstein Barr-related diseases.
Latest Patents
Stephanie holds a patent for her invention titled "Polypeptides to inhibit Epstein Barr viral protein BHRF1 and B cell lymphoma family proteins." This innovative work provides designed polypeptides that selectively bind to and inhibit the Epstein Barr protein BHRF1, as well as B cell lymphoma family proteins. The implications of her invention are profound, as it offers potential treatments for Epstein Barr-related diseases and cancer.
Career Highlights
Stephanie is affiliated with the University of Washington, where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Throughout her career, Stephanie has collaborated with notable researchers, including Erik Procko and David Baker. These partnerships have enhanced her research and contributed to the success of her innovative projects.
Conclusion
Stephanie Ann Berger is a trailblazer in the field of cancer research, with her patented innovations paving the way for new treatments. Her dedication to science and collaboration with esteemed colleagues exemplify her commitment to making a difference in the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile